Venrock, Aisling Capital lead $18.5 mln round for Spirox

Spirox Inc. said Monday it closed an $18.5 million Series B round of financing led by Venrock and Aisling Capital. Existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participated in the round. Menlo Park, California-based Spirox is a medical device company focused on developing minimally invasive technologies to treat nasal obstruction.

North AmericaUSBriefs